Array
(
[id] => 19608000
[patent_doc_number] => 12156859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Methods of and compositions for treating obesity, obesity-related diseases or cancers using a N6-methyllysine/l-lysine mixture
[patent_app_type] => utility
[patent_app_number] => 18/082723
[patent_app_country] => US
[patent_app_date] => 2022-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 27
[patent_no_of_words] => 6648
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082723
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082723 | Methods of and compositions for treating obesity, obesity-related diseases or cancers using a N6-methyllysine/l-lysine mixture | Dec 15, 2022 | Issued |
Array
(
[id] => 17883025
[patent_doc_number] => 20220298502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => NUCLEASE AND NICKASE FUSION PROTEINS FOR INCREASED HOMOLOGOUS RECOMBINATION IN MAMMALIAN CELLS
[patent_app_type] => utility
[patent_app_number] => 17/696131
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696131 | NUCLEASE AND NICKASE FUSION PROTEINS FOR INCREASED HOMOLOGOUS RECOMBINATION IN MAMMALIAN CELLS | Mar 15, 2022 | Abandoned |